Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot clinical trial of memantine for cognitive deficit in multiple sclerosis
2006-003887-76Phase 4Completed
- Sponsor
- Innovative Cellular Therapeutics
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of memantine in multiple sclerosis (MS), sponsored by Innovative Cellular Therapeutics. Primary endpoint: Neuropsychological tests (primary). Started Mar 2010; status: completed.
02
Drugs
memantine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2006-003887-76.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003887-76.